SlideShare a Scribd company logo
1 of 37
CHEMOTHERAPY OF
BREAST CANCER
BY:
SACHIN PRAKASH
PHARM D 3RD YEAR
KARAVALI COLLEGE OF
PHARMACY,MANGALORE
13Q1624
INTRODUCTION
OBreast cancer is cancer that
develops from breast tissue.
OBreast cancer ,the second leading
cause of cancer deaths in women,is
the disease women fear most.
OBreast cancer can also occur in
men, but it's far less common.
• In the last 30 years, doctors have made great
strides in early diagnosis and treatment of the
disease and in reducing breast cancer
deaths.
• 80% of breast cancers occur in women older
than age 50.
• In 1975, a diagnosis of breast cancer usually
meant radical mastectomy – (removal of the
entire breast along with underarm lymph
nodes and muscles underneath the breast. )
• Today, radical mastectomy is rarely
performed. Instead, there are more and better
treatment options, and many women are
candidates for breast-sparing operations.
ETIOLOGY
O The two variables most strongly associated
with the occurrence of breast cancer are
gender and age.
O Breast cancer is also caused by a genetic
abnormality (a “mistake” in the genetic
material). However, only 5-10% of cancers are
due to an abnormality inherited from your
mother or father. About 90% of breast cancers
are due to genetic abnormalities that happen
as a result of the aging process and the “wear
and tear” of life in general.
TYPES OF BREAST CANCER
RISK FACTORS
O Gender: female (1% males)
O Race: more common in whites.
O Age: increases as a woman gets older.
O Relative : (mother or sister).
O Menstrual history :early on set late
menopause
O Childbirth: first child After the age of 30 or having
no children at all.
Pregnancy and breastfeeding are protective against breast
cancer
• Obesity
• Diet: Fat & Alcohol
• Lack of Physical Activity: Stress
• Radiation Exposure
• History of cancer: Breast, Uterus, Cervix, Ovary
• Hormones: Estrogens in Hormone replacement therapy &
Birth control pills
• Genetics:Certain conditions that are inheritated
70% have no risk factors
CLINICAL MANIFESTATION
General
■ The patient may not have any symptoms, as breast cancer
may be detected in asymptomatic patients though routine
screening mammography.
Local Signs and Symptoms
■ A painless, palpable lump is most common.
■ Less common: Pain; Nipple discharge, Retraction or
dimpling,
Skin edema, Redness or warmth.
■ Palpable local-regional lymph nodes may also be present.
Signs and Symptoms of Systemic Metastases
■ Depends on the site of metastases, but may include bone
pain,
difficulty breathing, abdominal pain or enlargement, jaundice,
mental status changes.
PATHOPHYSIOLOGY
O Breast cancer is a malignant tumor that starts in the cells of
the breast. Like other cancers, there are several factors that
can raise the risk of getting breast cancer. Damage to the
DNA and genetic mutations can lead to breast cancer have
been experimentally linked to estrogen exposure. Some
individuals inherit defects in the DNA and genes like the
BRCA1, BRCA2 and P53 among others. Those with a
family history of ovarian or breast cancer thus are at an
increased risk of breast cancer.
O The immune system normally seeks out cancer cells and
cells with damaged DNA and destroys them. Breast cancer
may be a result of failure of such an effective immune
defence and surveillance.
O These are several signalling systems of growth factors and
other mediators that interact between stromal cells and
epithelial cells. Disrupting these may lead to breast cancer
as well.
DIAGNOSIS
O Laboratory Tests
■ Tumor markers such as cancer antigen (CA 27.29) or
carcinoembryonic antigen (CEA) may be elevated.
■ Alkaline phosphatase or liver function tests may be
elevated in
metastatic disease.
O Other Diagnostic Tests
■ Mammogram (with or without ultrasound, breast MRI or
both).
■ Biopsy for pathology review and determination of tumor
estrogen/progesterone receptor (ER/PR) status and
HER2 status.
■ Systemic staging tests may include: chest x-ray, chest CT,
bone scan, abdominal CT or ultrasound or MRI.
Mammogram of normal
and cancer breast.
TREATMENT
The main types of treatment for breast
cancer are:
O Surgery.
O Radiation therapy.
O Chemotherapy.
O Hormone therapy.
O Targeted therapy.
O Bone-directed therapy.
SURGERY
O Surgery aims to remove the breast cancer
with a margin (border) of normal tissue to
reduce the risk of the cancer coming back
in the breast (known as local
recurrence) and to try to stop any spread
in the body. The amount of tissue
removed depends on the area of the
breast affected and the size of the
cancer in the breast.
TYPES OF SURGERY
1) Breast-conserving surgery
O This type of surgery is sometimes called partial
(or segmental) mastectomy. It is also
sometimes called lumpectomy or
quadrantectomy. In this surgery, only the part of
the breast containing the cancer is removed. The
goal is to remove the cancer as well as some
surrounding normal tissue.
O side effects: Include pain, temporary swelling,
tenderness, and hard scar tissue that forms in the
surgical site. As with all operations, bleeding and
infection at the surgery site are also possible.
2) Mastectomy
Mastectomy is surgery to remove the entire breast.
All of the breast tissue is removed, sometimes along
with other nearby tissues.
a) Simple mastectomy: Also called total
mastectomy, the surgeon removes the entire
breast, including the nipple, but does not remove
underarm lymph nodes or muscle tissue from
beneath the breast.
b) Skin-sparing mastectomy: In this procedure,
most of the skin over the breast (other than the
nipple and areola) is left intact. This approach is
only used when immediate breast reconstruction is
planned.
c) Modified radical mastectomy: This procedure is
a simple mastectomy and removal of axillary
(underarm) lymph nodes.
Radical mastectomy: In this extensive operation,
the surgeon removes the entire breast, axillary lymph
nodes, and the pectoral (chest wall) muscles under
the breast.
side effects: wound infection, hematoma (buildup of
blood in the wound), and seroma (buildup of clear fluid in
the wound).
3) Lymph node surgery
a) Axillary lymph node dissection (ALND): In this
procedure, anywhere from about 10 to 40 lymph
nodes are removed from the area under the arm
(axilla) and checked for cancer spread.
b) Sentinel lymph node biopsy (SLNB): Removes the
first lymph node(s) to which a tumor is likely to
spread (these are called the sentinel nodes).
Removing many lymph nodes increases the risk of
lymphedema , to lower this risk, doctors may use a
sentinel lymph node biopsy (SLNB).
side effects: As with any operation, pain, swelling,
bleeding, and infection are possible.
4) Reconstructive surgery
• After having a mastectomy (or some breast-conserving
surgeries), a woman might want to consider having the
breast mound rebuilt; this is called breast reconstruction.
These procedures are done to restore the breast's
appearance after surgery.
Chronic pain after breast surgery
Some women have problems with nerve (neuropathic) pain
in the chest wall, armpit, and/or arm after surgery that
doesn’t go away over time. This is called post-
mastectomy pain syndrome (PMPS) because it was first
described in women who had mastectomies, but it can also
happen after breast-conserving therapy.
RADIATION THERAPY
O Radiation therapy (also called radiotherapy) uses
high-energy rays to kill cancer cells. It affects cells
only in the part of the body that is treated with the
radiation. Breast cancer radiation therapy may be
used to destroy any remaining mutated cells that
remain in the breast or armpit area after surgery.
O Radiation is also used to treat cancer that has
spread to other areas, for example to the bones or
brain.
O Radiation therapy can be given externally
(external beam radiation) or internally
(brachytherapy).
External beam radiation
O This is the most common type of radiation
therapy for women with breast cancer.
The radiation is focused from a
machine outside the body on the area
affected by the cancer.
O The extent of radiation depends on
whether mastectomy or breast-conserving
surgery (BCS) was done and whether or
not lymph nodes are involved.
O If mastectomy was done and no lymph
nodes had cancer, radiation is targeted at
the chest wall and the places where any
drains exited the body.
• If BCS was done, most often the entire breast
gets radiation, and an extra boost of radiation is
given to the area in the breast where the cancer
was removed to prevent it from coming back in
that area.
• If cancer was found in the lymph nodes under
the arm, radiation may be given to this area as
well. In some cases, the area treated may also
include supraclavicular lymph nodes (nodes
above the collarbone) and internal mammary
lymph nodes (nodes beneath the breast bone in
the center of the chest).
• Breast radiation is most commonly given 5 days
a week (Monday through Friday) for about 5
to 6 weeks.
Internal Radiation
O Sometimes called partial-breast
radiation or brachytherapy, for use after
lumpectomy. Internal radiation methods
typically use small pieces of radioactive
material, called seeds, which are placed in
the area around where the cancer was.
The seeds emit radiation into the
surrounding tissue. The area that's very
close to the site of the original cancer is
the area that is at highest risk of
recurrencence.
TYPES:
1)Interstitial brachytherapy: In this approach, several
small, hollow tubes called catheters are inserted into the
breast around the area where the cancer was removed
and are left in place for several days. Radioactive pellets
are inserted into the catheters for short periods of time
each day and then removed.
2)Intracavitary brachytherapy: This is the most common
type of brachytherapy. A device is put into the space left
from BCS and is left in place until treatment is complete.
There are several different devices that can be used:
MammoSite®, SAVI®, Axxent®, and Contura®.
Mammosite insertion Mammosite tube
SIDE EFFECTS
O Radiation therapy can have side effects,
and these vary from person to person.
O The most common side-effects are:
O Sunburn-type skin irritation of the targeted
area (which may range from mild to
intense)
O Red, dry, tender, or itchy skin
O Breast heaviness
O fatigue
CHEMOTHERAPY
O Chemotherapy is a treatment using anti-
cancer (also called cytotoxic) drugs
which aims to destroy cancer cells. It is
known as a systemic treatment.
O Many different types of chemotherapy
drugs are used to treat breast cancer.
They can be given in different ways and in
different combinations, according to an
individual’s situation.
Chemotherapy can be given in several ways. For breast cancer
the drugs are most commonly given:
• into a vein (intravenously)
• by mouth (orally) as a tablet or capsule.
1) Intravenous chemotherapy :The most
common way involves inserting a small needle and plastic tube
called a cannula into a vein, either in the back of the hand or lower
arm. The needle is removed and the plastic tube left in place. The
diluted drugs are then slowly injected into the vein. If a large
volume of fluid is used it can be given as an infusion (drip) through
the cannula over a fixed period of time.
• The cannula will usually be on the opposite arm to where you
had (or are having) surgery. This is to avoid the risk of
lymphoedema.
2) Oral chemotherapy: This is chemotherapy
taken by mouth and it may be given either as tablets or capsules.
3) Electrochemotherapy : It is a new treatment
and is not widely available. It’s sometimes used to treat breast
cancer that has spread to the skin. Chemotherapy is injected
either directly into the area of skin affected or into the
bloodstream. An electric pulse is then used to help the
chemotherapy reach the cancer cells. Once inside the cancer
cells, the chemotherapy destroys them.
SIDE EFFECTS:
• risk of infection from not having enough white blood
cells, anaemia (a drop in the number of red blood cells)
and bruising and bleeding
• sickness (nausea) and vomiting
• hair loss or thinning
• sore mouth (mucositis)
• mouth ulcers
• fatigue.
Chemotherapy Regimens
• Doxorubicin 60 mg/m2 IV
• Cyclophosphamide 600 mg/m2
IV
• Fluorouracil 500 mg/m2 IV
• Epirubicin 100 mg/m2 IV bolus
• Methotrexate 40 mg/m2 IV,
• Paclitaxel 175 mg/m2 IV
Hormone therapy
O Hormone therapy is another form of
systemic therapy. It is most often used as
an adjuvant therapy to reduce the risk of
the cancer coming back after surgery, but
it can be used as neoadjuvant treatment,
as well. It is also used to treat cancer that
has come back after treatment or has
spread.
O A woman's ovaries are the main source of
the hormone estrogen until
menopause.
O Estrogen promotes the growth of cancers
that are hormone receptor-positive.
Hormonal therapy medicines treat hormone-
receptor-positive breast cancers in two ways:
• By lowering the amount of the hormone estrogen in the
body.
• By blocking the action of estrogen on breast cancer cells.
• Hormonal therapy medicines are NOT effective against
hormone-receptor-negative breast cancers.
Drugs that block estrogen
1) Tamoxifen: Tamoxifen blocks estrogen receptors in breast
cancer cells.it is called a selective estrogen receptor
modulator or SERM.
• This drug is taken by mouth, most often as a pill.
• The most common side effects of these drugs
include fatigue, hot flashes, vaginal dryness or discharge, and
mood swings.
2) Toremifene (Fareston®): Toremifene is a drug similar to
tamoxifen. It is also a SERM and has similar side effects.
3) Fulvestrant (Faslodex®): Fulvestrant is a drug that first blocks
the estrogen receptor and then also eliminates it temporarily. It is
not a SERM – it acts like an anti-estrogen throughout the body.
Treatments to lower estrogen levels
1) Aromatase inhibitors (AIs): letrozole (Femara), anastrozole
(Arimidex), and exemestane (Aromasin). They work by
blocking an enzyme (aromatase) in fat tissue that is responsible
for making small amounts of estrogen in post-menopausal
women. They cannot stop the ovaries from making estrogen,
aIso are taken daily as pills.
2) Ovarian ablation: Removing or shutting down the ovaries
(ovarian oblation), the main source of estrogens, effectively
makes the woman post-menopausal.
• Permanent ovarian ablation can be done by surgically removing
the ovaries. This operation is called anoophorectomy,also done
with drugs called luteinizing hormone-releasing
hormone (LHRH) analogs, such as goserelin (Zoladex®) or
®
Less commonly used types of hormone therapy
• Megestrol acetate (Megace®) is a progesterone-like drug
used that can be used as a hormone treatment of advanced
breast cancer.
• Androgens (male hormones) may rarely be considered
after other hormone treatments for advanced breast cancer
have been tried. They are sometimes effective, but they can
cause masculine characteristics to develop such as an
increase in body hair and a deeper voice.
Targeted therapy
O Targeted cancer therapies are drugs or other
substances that block the growth and spread
of cancer by interfering with
specific molecules ("molecular targets") that
are involved in the growth, progression, and
spread of cancer. Targeted cancer therapies
are sometimes called "molecularly targeted
drugs," "molecularly targeted therapies,"
"precision medicines“.
O These therapies include hormone
therapies, signal transduction inhibitors, gene
expressionmodulator, apoptosis inducer, angi
ogenesis inhibitor, immunotherapies,
and toxin delivery molecules.
SIDE EFFECTS
The most common side effects seen with targeted therapies
are diarrhea and liver problems, such as hepatitis and elevated
liver enzymes. Other side effects seen with targeted therapies
include:
• Skin problems (acneiform rash, dry skin, nail changes, hair
depigmentation)
• Problems with blood clotting and wound healing
• High blood pressure
• Gastrointestinal perforation (a rare side effect of some
targeted therapies)
• SOME MONOCLONAL ANTIBODIES
• Trastuzumab (Herceptin)- man-made versions of a very
specific immune system protein. They are given into a vein
(IV).
• Pertuzumab (Perjeta®)- IV
• Ado-trastuzumab emtansine (Kadcyla™)-attached to a
chemotherapy drug. It is also given IV.
• Lapatinib (Tykerb)- Not an antibody. It is given as a pill.
Bone-directed therapy
O When cancer spreads to bones, it can cause pain
and lead to bones breaking (fractures) and other
problems. Drugs like Bisphosphonates and
Denosumab can lower the risk of these problems.
Bisphosphonates
O Bisphosphonates are drugs that can be used to
help strengthen bones and reduce the risk of
fractures and pain in bones that have been
weakened by metastatic breast cancer. Examples
include pamidronate (Aredia®) and zoledronic
acid (Zometa®). They are given intravenously
(IV).
O Bisphosphonates may also help against bone
thinning (osteoporosis) that can result from
treatment with aromatase inhibitors or from early
menopause as a side effect of chemotherapy.
SIDE EFFECTS
• Flu-like symptoms and bone pain
• Kidney problems, so people with poor kidney function
may not be able to be treated with these drugs.
• Osteonecrosis (damage) in the jaw bones or ONJ
Denosumab
• Denosumab (Xgeva®, Prolia®) is another drug that
can help reduce the risk of problems from breast
cancer metastasis to the bone. It works differently
from bisphosphonates.
• it seemed to help prevent problems like fractures
(breaks) better than zoledronic acid. It also can help
bones even after bisphosphonates stop working.
• drug is injected under the skin every 4 weeks.
SIDE EFFECTS
O low blood levels of calcium and phosphate
O ONJ
O does not seem to affect the kidneys, so it is
safe to take if patient have kidney problems.
Denosumab can also be used to strengthen
bones in breast cancer patients with weak
bones who are being treated with aromatase
inhibitors. When it is used for this purpose, it is
given less often (usually every 6 months).
Thank you
for your
Support…..

More Related Content

What's hot

Overview and classification of chemotherapeutic agents and theory
Overview and classification of  chemotherapeutic agents and theoryOverview and classification of  chemotherapeutic agents and theory
Overview and classification of chemotherapeutic agents and theory
Saurabh Gupta
 
Anticancer drugs 4 cytotoxic drugs and antibiotics
Anticancer drugs 4 cytotoxic drugs and antibioticsAnticancer drugs 4 cytotoxic drugs and antibiotics
Anticancer drugs 4 cytotoxic drugs and antibiotics
Subramani Parasuraman
 
Anticancer drugs 1 introduction and classification
Anticancer drugs 1 introduction and classificationAnticancer drugs 1 introduction and classification
Anticancer drugs 1 introduction and classification
Subramani Parasuraman
 

What's hot (20)

Principles of cancer chemotherapy: a deep insight by RxVichuZ!
Principles of cancer chemotherapy: a deep insight by RxVichuZ!Principles of cancer chemotherapy: a deep insight by RxVichuZ!
Principles of cancer chemotherapy: a deep insight by RxVichuZ!
 
Overview and classification of chemotherapeutic agents and theory
Overview and classification of  chemotherapeutic agents and theoryOverview and classification of  chemotherapeutic agents and theory
Overview and classification of chemotherapeutic agents and theory
 
Class anticancer drugs
Class anticancer drugsClass anticancer drugs
Class anticancer drugs
 
Breast Cancer
Breast CancerBreast Cancer
Breast Cancer
 
cancer chemotherapy
cancer chemotherapycancer chemotherapy
cancer chemotherapy
 
Introduction to chemotherapy of cancer
Introduction to chemotherapy of cancerIntroduction to chemotherapy of cancer
Introduction to chemotherapy of cancer
 
Principles of cancer chemotherapy
Principles of cancer chemotherapyPrinciples of cancer chemotherapy
Principles of cancer chemotherapy
 
Anticancer drugs 4 cytotoxic drugs and antibiotics
Anticancer drugs 4 cytotoxic drugs and antibioticsAnticancer drugs 4 cytotoxic drugs and antibiotics
Anticancer drugs 4 cytotoxic drugs and antibiotics
 
Cancer treatment
Cancer treatment Cancer treatment
Cancer treatment
 
Breast Cancer
Breast CancerBreast Cancer
Breast Cancer
 
10.ANTICANCER DRUGS
10.ANTICANCER DRUGS10.ANTICANCER DRUGS
10.ANTICANCER DRUGS
 
Guidelines for rational use of antibiotics in surgical prophylaxis
Guidelines for rational use of antibiotics in surgical prophylaxisGuidelines for rational use of antibiotics in surgical prophylaxis
Guidelines for rational use of antibiotics in surgical prophylaxis
 
Classification of cancer
Classification of cancerClassification of cancer
Classification of cancer
 
Alkylating agents
Alkylating agentsAlkylating agents
Alkylating agents
 
Cancer chemotherapy
Cancer  chemotherapyCancer  chemotherapy
Cancer chemotherapy
 
Anti metabolites
Anti metabolitesAnti metabolites
Anti metabolites
 
Tamoxifen
TamoxifenTamoxifen
Tamoxifen
 
Anticancer drugs 1 introduction and classification
Anticancer drugs 1 introduction and classificationAnticancer drugs 1 introduction and classification
Anticancer drugs 1 introduction and classification
 
Targeted Therapies in Cancer
Targeted Therapies in CancerTargeted Therapies in Cancer
Targeted Therapies in Cancer
 
Anti Cancer Drugs
Anti Cancer DrugsAnti Cancer Drugs
Anti Cancer Drugs
 

Similar to Chemotherapy of breast cancer

Breast disorder & Mastectomy -a7med mo7amed
Breast disorder & Mastectomy -a7med mo7amedBreast disorder & Mastectomy -a7med mo7amed
Breast disorder & Mastectomy -a7med mo7amed
a7med mo7amed
 

Similar to Chemotherapy of breast cancer (20)

Clinical Pharmacology of Breast Cancer Evaluation
Clinical Pharmacology of Breast Cancer EvaluationClinical Pharmacology of Breast Cancer Evaluation
Clinical Pharmacology of Breast Cancer Evaluation
 
Breat cancer Therapy
Breat cancer TherapyBreat cancer Therapy
Breat cancer Therapy
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Breast cancer ppt med surg
Breast cancer ppt med surgBreast cancer ppt med surg
Breast cancer ppt med surg
 
Mx of breast cancer
Mx of breast cancer  Mx of breast cancer
Mx of breast cancer
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Uterine cancer.pptx
Uterine cancer.pptxUterine cancer.pptx
Uterine cancer.pptx
 
Male breast cancer
Male breast cancerMale breast cancer
Male breast cancer
 
breast cancer- nurses responsibility and advoacy
breast cancer- nurses responsibility and advoacybreast cancer- nurses responsibility and advoacy
breast cancer- nurses responsibility and advoacy
 
Male Breast Cancer : Symptoms, diagnosis and treatment
Male Breast Cancer : Symptoms, diagnosis and treatmentMale Breast Cancer : Symptoms, diagnosis and treatment
Male Breast Cancer : Symptoms, diagnosis and treatment
 
BREST CARSINOMA and its anatomy,resources.pptx
BREST CARSINOMA and its anatomy,resources.pptxBREST CARSINOMA and its anatomy,resources.pptx
BREST CARSINOMA and its anatomy,resources.pptx
 
Breast Cancer kholy
Breast Cancer kholyBreast Cancer kholy
Breast Cancer kholy
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
BREAST CANCER.pptx
BREAST CANCER.pptxBREAST CANCER.pptx
BREAST CANCER.pptx
 
Endometrial cancer
Endometrial cancerEndometrial cancer
Endometrial cancer
 
Gynecology 5th year, 10th lecture (Dr. Hanaa)
Gynecology 5th year, 10th lecture (Dr. Hanaa)Gynecology 5th year, 10th lecture (Dr. Hanaa)
Gynecology 5th year, 10th lecture (Dr. Hanaa)
 
Breast cancer managment
Breast cancer managmentBreast cancer managment
Breast cancer managment
 
breast cancer.pptx
breast cancer.pptxbreast cancer.pptx
breast cancer.pptx
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Breast disorder & Mastectomy -a7med mo7amed
Breast disorder & Mastectomy -a7med mo7amedBreast disorder & Mastectomy -a7med mo7amed
Breast disorder & Mastectomy -a7med mo7amed
 

Recently uploaded

Recently uploaded (20)

Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 

Chemotherapy of breast cancer

  • 1. CHEMOTHERAPY OF BREAST CANCER BY: SACHIN PRAKASH PHARM D 3RD YEAR KARAVALI COLLEGE OF PHARMACY,MANGALORE 13Q1624
  • 2. INTRODUCTION OBreast cancer is cancer that develops from breast tissue. OBreast cancer ,the second leading cause of cancer deaths in women,is the disease women fear most. OBreast cancer can also occur in men, but it's far less common.
  • 3. • In the last 30 years, doctors have made great strides in early diagnosis and treatment of the disease and in reducing breast cancer deaths. • 80% of breast cancers occur in women older than age 50. • In 1975, a diagnosis of breast cancer usually meant radical mastectomy – (removal of the entire breast along with underarm lymph nodes and muscles underneath the breast. ) • Today, radical mastectomy is rarely performed. Instead, there are more and better treatment options, and many women are candidates for breast-sparing operations.
  • 4. ETIOLOGY O The two variables most strongly associated with the occurrence of breast cancer are gender and age. O Breast cancer is also caused by a genetic abnormality (a “mistake” in the genetic material). However, only 5-10% of cancers are due to an abnormality inherited from your mother or father. About 90% of breast cancers are due to genetic abnormalities that happen as a result of the aging process and the “wear and tear” of life in general.
  • 6. RISK FACTORS O Gender: female (1% males) O Race: more common in whites. O Age: increases as a woman gets older. O Relative : (mother or sister). O Menstrual history :early on set late menopause O Childbirth: first child After the age of 30 or having no children at all. Pregnancy and breastfeeding are protective against breast cancer
  • 7. • Obesity • Diet: Fat & Alcohol • Lack of Physical Activity: Stress • Radiation Exposure • History of cancer: Breast, Uterus, Cervix, Ovary • Hormones: Estrogens in Hormone replacement therapy & Birth control pills • Genetics:Certain conditions that are inheritated 70% have no risk factors
  • 8. CLINICAL MANIFESTATION General ■ The patient may not have any symptoms, as breast cancer may be detected in asymptomatic patients though routine screening mammography. Local Signs and Symptoms ■ A painless, palpable lump is most common. ■ Less common: Pain; Nipple discharge, Retraction or dimpling, Skin edema, Redness or warmth. ■ Palpable local-regional lymph nodes may also be present. Signs and Symptoms of Systemic Metastases ■ Depends on the site of metastases, but may include bone pain, difficulty breathing, abdominal pain or enlargement, jaundice, mental status changes.
  • 9. PATHOPHYSIOLOGY O Breast cancer is a malignant tumor that starts in the cells of the breast. Like other cancers, there are several factors that can raise the risk of getting breast cancer. Damage to the DNA and genetic mutations can lead to breast cancer have been experimentally linked to estrogen exposure. Some individuals inherit defects in the DNA and genes like the BRCA1, BRCA2 and P53 among others. Those with a family history of ovarian or breast cancer thus are at an increased risk of breast cancer. O The immune system normally seeks out cancer cells and cells with damaged DNA and destroys them. Breast cancer may be a result of failure of such an effective immune defence and surveillance. O These are several signalling systems of growth factors and other mediators that interact between stromal cells and epithelial cells. Disrupting these may lead to breast cancer as well.
  • 10. DIAGNOSIS O Laboratory Tests ■ Tumor markers such as cancer antigen (CA 27.29) or carcinoembryonic antigen (CEA) may be elevated. ■ Alkaline phosphatase or liver function tests may be elevated in metastatic disease. O Other Diagnostic Tests ■ Mammogram (with or without ultrasound, breast MRI or both). ■ Biopsy for pathology review and determination of tumor estrogen/progesterone receptor (ER/PR) status and HER2 status. ■ Systemic staging tests may include: chest x-ray, chest CT, bone scan, abdominal CT or ultrasound or MRI. Mammogram of normal and cancer breast.
  • 11. TREATMENT The main types of treatment for breast cancer are: O Surgery. O Radiation therapy. O Chemotherapy. O Hormone therapy. O Targeted therapy. O Bone-directed therapy.
  • 12. SURGERY O Surgery aims to remove the breast cancer with a margin (border) of normal tissue to reduce the risk of the cancer coming back in the breast (known as local recurrence) and to try to stop any spread in the body. The amount of tissue removed depends on the area of the breast affected and the size of the cancer in the breast.
  • 13. TYPES OF SURGERY 1) Breast-conserving surgery O This type of surgery is sometimes called partial (or segmental) mastectomy. It is also sometimes called lumpectomy or quadrantectomy. In this surgery, only the part of the breast containing the cancer is removed. The goal is to remove the cancer as well as some surrounding normal tissue. O side effects: Include pain, temporary swelling, tenderness, and hard scar tissue that forms in the surgical site. As with all operations, bleeding and infection at the surgery site are also possible.
  • 14. 2) Mastectomy Mastectomy is surgery to remove the entire breast. All of the breast tissue is removed, sometimes along with other nearby tissues. a) Simple mastectomy: Also called total mastectomy, the surgeon removes the entire breast, including the nipple, but does not remove underarm lymph nodes or muscle tissue from beneath the breast. b) Skin-sparing mastectomy: In this procedure, most of the skin over the breast (other than the nipple and areola) is left intact. This approach is only used when immediate breast reconstruction is planned. c) Modified radical mastectomy: This procedure is a simple mastectomy and removal of axillary (underarm) lymph nodes.
  • 15. Radical mastectomy: In this extensive operation, the surgeon removes the entire breast, axillary lymph nodes, and the pectoral (chest wall) muscles under the breast. side effects: wound infection, hematoma (buildup of blood in the wound), and seroma (buildup of clear fluid in the wound).
  • 16. 3) Lymph node surgery a) Axillary lymph node dissection (ALND): In this procedure, anywhere from about 10 to 40 lymph nodes are removed from the area under the arm (axilla) and checked for cancer spread. b) Sentinel lymph node biopsy (SLNB): Removes the first lymph node(s) to which a tumor is likely to spread (these are called the sentinel nodes). Removing many lymph nodes increases the risk of lymphedema , to lower this risk, doctors may use a sentinel lymph node biopsy (SLNB). side effects: As with any operation, pain, swelling, bleeding, and infection are possible.
  • 17. 4) Reconstructive surgery • After having a mastectomy (or some breast-conserving surgeries), a woman might want to consider having the breast mound rebuilt; this is called breast reconstruction. These procedures are done to restore the breast's appearance after surgery. Chronic pain after breast surgery Some women have problems with nerve (neuropathic) pain in the chest wall, armpit, and/or arm after surgery that doesn’t go away over time. This is called post- mastectomy pain syndrome (PMPS) because it was first described in women who had mastectomies, but it can also happen after breast-conserving therapy.
  • 18. RADIATION THERAPY O Radiation therapy (also called radiotherapy) uses high-energy rays to kill cancer cells. It affects cells only in the part of the body that is treated with the radiation. Breast cancer radiation therapy may be used to destroy any remaining mutated cells that remain in the breast or armpit area after surgery. O Radiation is also used to treat cancer that has spread to other areas, for example to the bones or brain. O Radiation therapy can be given externally (external beam radiation) or internally (brachytherapy).
  • 19. External beam radiation O This is the most common type of radiation therapy for women with breast cancer. The radiation is focused from a machine outside the body on the area affected by the cancer. O The extent of radiation depends on whether mastectomy or breast-conserving surgery (BCS) was done and whether or not lymph nodes are involved. O If mastectomy was done and no lymph nodes had cancer, radiation is targeted at the chest wall and the places where any drains exited the body.
  • 20. • If BCS was done, most often the entire breast gets radiation, and an extra boost of radiation is given to the area in the breast where the cancer was removed to prevent it from coming back in that area. • If cancer was found in the lymph nodes under the arm, radiation may be given to this area as well. In some cases, the area treated may also include supraclavicular lymph nodes (nodes above the collarbone) and internal mammary lymph nodes (nodes beneath the breast bone in the center of the chest). • Breast radiation is most commonly given 5 days a week (Monday through Friday) for about 5 to 6 weeks.
  • 21. Internal Radiation O Sometimes called partial-breast radiation or brachytherapy, for use after lumpectomy. Internal radiation methods typically use small pieces of radioactive material, called seeds, which are placed in the area around where the cancer was. The seeds emit radiation into the surrounding tissue. The area that's very close to the site of the original cancer is the area that is at highest risk of recurrencence.
  • 22. TYPES: 1)Interstitial brachytherapy: In this approach, several small, hollow tubes called catheters are inserted into the breast around the area where the cancer was removed and are left in place for several days. Radioactive pellets are inserted into the catheters for short periods of time each day and then removed. 2)Intracavitary brachytherapy: This is the most common type of brachytherapy. A device is put into the space left from BCS and is left in place until treatment is complete. There are several different devices that can be used: MammoSite®, SAVI®, Axxent®, and Contura®. Mammosite insertion Mammosite tube
  • 23. SIDE EFFECTS O Radiation therapy can have side effects, and these vary from person to person. O The most common side-effects are: O Sunburn-type skin irritation of the targeted area (which may range from mild to intense) O Red, dry, tender, or itchy skin O Breast heaviness O fatigue
  • 24. CHEMOTHERAPY O Chemotherapy is a treatment using anti- cancer (also called cytotoxic) drugs which aims to destroy cancer cells. It is known as a systemic treatment. O Many different types of chemotherapy drugs are used to treat breast cancer. They can be given in different ways and in different combinations, according to an individual’s situation.
  • 25. Chemotherapy can be given in several ways. For breast cancer the drugs are most commonly given: • into a vein (intravenously) • by mouth (orally) as a tablet or capsule. 1) Intravenous chemotherapy :The most common way involves inserting a small needle and plastic tube called a cannula into a vein, either in the back of the hand or lower arm. The needle is removed and the plastic tube left in place. The diluted drugs are then slowly injected into the vein. If a large volume of fluid is used it can be given as an infusion (drip) through the cannula over a fixed period of time. • The cannula will usually be on the opposite arm to where you had (or are having) surgery. This is to avoid the risk of lymphoedema. 2) Oral chemotherapy: This is chemotherapy taken by mouth and it may be given either as tablets or capsules.
  • 26. 3) Electrochemotherapy : It is a new treatment and is not widely available. It’s sometimes used to treat breast cancer that has spread to the skin. Chemotherapy is injected either directly into the area of skin affected or into the bloodstream. An electric pulse is then used to help the chemotherapy reach the cancer cells. Once inside the cancer cells, the chemotherapy destroys them. SIDE EFFECTS: • risk of infection from not having enough white blood cells, anaemia (a drop in the number of red blood cells) and bruising and bleeding • sickness (nausea) and vomiting • hair loss or thinning • sore mouth (mucositis) • mouth ulcers • fatigue.
  • 27. Chemotherapy Regimens • Doxorubicin 60 mg/m2 IV • Cyclophosphamide 600 mg/m2 IV • Fluorouracil 500 mg/m2 IV • Epirubicin 100 mg/m2 IV bolus • Methotrexate 40 mg/m2 IV, • Paclitaxel 175 mg/m2 IV
  • 28. Hormone therapy O Hormone therapy is another form of systemic therapy. It is most often used as an adjuvant therapy to reduce the risk of the cancer coming back after surgery, but it can be used as neoadjuvant treatment, as well. It is also used to treat cancer that has come back after treatment or has spread. O A woman's ovaries are the main source of the hormone estrogen until menopause. O Estrogen promotes the growth of cancers that are hormone receptor-positive.
  • 29. Hormonal therapy medicines treat hormone- receptor-positive breast cancers in two ways: • By lowering the amount of the hormone estrogen in the body. • By blocking the action of estrogen on breast cancer cells. • Hormonal therapy medicines are NOT effective against hormone-receptor-negative breast cancers. Drugs that block estrogen 1) Tamoxifen: Tamoxifen blocks estrogen receptors in breast cancer cells.it is called a selective estrogen receptor modulator or SERM. • This drug is taken by mouth, most often as a pill. • The most common side effects of these drugs include fatigue, hot flashes, vaginal dryness or discharge, and mood swings.
  • 30. 2) Toremifene (Fareston®): Toremifene is a drug similar to tamoxifen. It is also a SERM and has similar side effects. 3) Fulvestrant (Faslodex®): Fulvestrant is a drug that first blocks the estrogen receptor and then also eliminates it temporarily. It is not a SERM – it acts like an anti-estrogen throughout the body. Treatments to lower estrogen levels 1) Aromatase inhibitors (AIs): letrozole (Femara), anastrozole (Arimidex), and exemestane (Aromasin). They work by blocking an enzyme (aromatase) in fat tissue that is responsible for making small amounts of estrogen in post-menopausal women. They cannot stop the ovaries from making estrogen, aIso are taken daily as pills. 2) Ovarian ablation: Removing or shutting down the ovaries (ovarian oblation), the main source of estrogens, effectively makes the woman post-menopausal. • Permanent ovarian ablation can be done by surgically removing the ovaries. This operation is called anoophorectomy,also done with drugs called luteinizing hormone-releasing hormone (LHRH) analogs, such as goserelin (Zoladex®) or ®
  • 31. Less commonly used types of hormone therapy • Megestrol acetate (Megace®) is a progesterone-like drug used that can be used as a hormone treatment of advanced breast cancer. • Androgens (male hormones) may rarely be considered after other hormone treatments for advanced breast cancer have been tried. They are sometimes effective, but they can cause masculine characteristics to develop such as an increase in body hair and a deeper voice.
  • 32. Targeted therapy O Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules ("molecular targets") that are involved in the growth, progression, and spread of cancer. Targeted cancer therapies are sometimes called "molecularly targeted drugs," "molecularly targeted therapies," "precision medicines“. O These therapies include hormone therapies, signal transduction inhibitors, gene expressionmodulator, apoptosis inducer, angi ogenesis inhibitor, immunotherapies, and toxin delivery molecules.
  • 33. SIDE EFFECTS The most common side effects seen with targeted therapies are diarrhea and liver problems, such as hepatitis and elevated liver enzymes. Other side effects seen with targeted therapies include: • Skin problems (acneiform rash, dry skin, nail changes, hair depigmentation) • Problems with blood clotting and wound healing • High blood pressure • Gastrointestinal perforation (a rare side effect of some targeted therapies) • SOME MONOCLONAL ANTIBODIES • Trastuzumab (Herceptin)- man-made versions of a very specific immune system protein. They are given into a vein (IV). • Pertuzumab (Perjeta®)- IV • Ado-trastuzumab emtansine (Kadcyla™)-attached to a chemotherapy drug. It is also given IV. • Lapatinib (Tykerb)- Not an antibody. It is given as a pill.
  • 34. Bone-directed therapy O When cancer spreads to bones, it can cause pain and lead to bones breaking (fractures) and other problems. Drugs like Bisphosphonates and Denosumab can lower the risk of these problems. Bisphosphonates O Bisphosphonates are drugs that can be used to help strengthen bones and reduce the risk of fractures and pain in bones that have been weakened by metastatic breast cancer. Examples include pamidronate (Aredia®) and zoledronic acid (Zometa®). They are given intravenously (IV). O Bisphosphonates may also help against bone thinning (osteoporosis) that can result from treatment with aromatase inhibitors or from early menopause as a side effect of chemotherapy.
  • 35. SIDE EFFECTS • Flu-like symptoms and bone pain • Kidney problems, so people with poor kidney function may not be able to be treated with these drugs. • Osteonecrosis (damage) in the jaw bones or ONJ Denosumab • Denosumab (Xgeva®, Prolia®) is another drug that can help reduce the risk of problems from breast cancer metastasis to the bone. It works differently from bisphosphonates. • it seemed to help prevent problems like fractures (breaks) better than zoledronic acid. It also can help bones even after bisphosphonates stop working. • drug is injected under the skin every 4 weeks.
  • 36. SIDE EFFECTS O low blood levels of calcium and phosphate O ONJ O does not seem to affect the kidneys, so it is safe to take if patient have kidney problems. Denosumab can also be used to strengthen bones in breast cancer patients with weak bones who are being treated with aromatase inhibitors. When it is used for this purpose, it is given less often (usually every 6 months).